Spironolactone No Benefit for Knee OA in Older Adults

This article originally appeared here.
Share this content:
Spironolactone No Benefit for Knee OA in Older Adults
Spironolactone No Benefit for Knee OA in Older Adults

FRIDAY, June 3, 2016 (HealthDay News) -- For older adults with knee osteoarthritis (OA), spironolactone is not associated with improvements in symptoms, physical function, or health-related quality-of-life, according to a study published in the May issue of Arthritis Care & Research.

Marion E.T. McMurdo, M.B.Ch.B., M.D., from Ninewells Hospital and Medical School in Dundee, U.K., and colleagues conducted a randomized trial involving individuals aged ≥70 years with symptomatic knee OA. Eighty-six participants were randomized to 12 weeks of 25 mg daily oral spironolactone or placebo.

The researchers observed no significant improvement in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score between the groups (P = 0.19). Furthermore, no improvements were seen in WOMAC stiffness score (P = 0.58), WOMAC physical function score (P = 0.98), or EuroQol 5-domain 3L score (P = 0.34). The groups did not differ significantly in terms of cortisol, matrix metalloproteinase 3, and urinary C-telopeptide of type II collagen. The spironolactone group had more minor adverse events (47 versus 32), but there was no increase in death or hospitalization.

"Spironolactone did not improve symptoms, physical function, or health-related quality of life in older people with knee OA," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Florida Teen First Human Case of Another Mosquito-Borne Virus

Florida Teen First Human Case of Another Mosquito-Borne ...

First documented case of Keystone infection in a human

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

70 Sickened So Far in Salmonella-Tainted Melon Outbreak

Illnesses reported in Illinois, Indiana, Kentucky, Michigan, Missouri, Ohio, and Tennessee

AAFP Still Recommends CRC Screening From Age 50 to 75

AAFP Still Recommends CRC Screening From Age 50 ...

Despite ACS change to start screening from age 45 years, AAFP agrees with USPSTF recommendation

is free, fast, and customized just for you!




Already a member?

Sign In Now »